Sector Update: Healthcare Healthcare

By
A A A

Healthcare shares were fairly flat in pre-market trade on Tuesday.

In healthcare stocks news, GW Pharmaceuticals ( GWPH ) shares were up 6% pre-market after the company said preliminary data from a trial into its Epidiolex treatment for drug-resistant epilepsy showed positive results.

The company released physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with GW's investigational cannabidiol ( CBD ) product candidate for a period of 12 weeks.

And, Galena Biopharma, Inc. ( GALE ), a biopharmaceutical company developing and commercializing oncology treatments, completed the enrollment in the company's Phase 2a clinical trial for a ovarian and endometrial cancer prevention treatment.

GALE was up about 7% pre-market.

Finally, Isis Pharmaceuticals ( ISIS ) says it has earned a $10 million milestone payment from Biogen Idec ( BIIB ) associated with the validation of an undisclosed target to treat a neurological disorder. This is the first milestone payment under their 2013 strategic collaboration to advance the treatment of neurological disorders.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: GWPH , CBD , GALE , ISIS , BIIB

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com